
Surendran will be joining Metropolis Healthcare Limited as CEO, effective from 2nd January 2023.
Digital developments driving growth for home COVID-19 have been responsible for the exponential growth of home diagnostics.
Worldwide, the estimated incidence of Down Syndrome is between 1 in 1,000 to 1 in 1,100 live births. In India…
Vijaya Diagnostic Centre Rs 1,895-crore IPO will open for subscription on 1 September, at a price band of Rs 522-531…
Vijaya Diagnostic Centre IPO will open for subscription on 1 September 2021 and close on 3 September.
Krsnaa Diagnostics, whose IPO saw 64.40 times subscription, is likely to finalise the share allotment on Thursday, 12 August 2021.
Krsnaa Diagnostics Rs 1,213-crore IPO will open for subscription on Wednesday, 4 August 2021, at a price band of Rs…
Krsnaa Diagnostics filed draft papers with the market regulator Securities and Exchange Board of India (Sebi) for an initial public…
The diagnostic initiative will be available across Metropolis centres in Mumbai Metropolis Healthcare has launched ‘The Metropolis Marathon Package’ a…
Pan India study of 14,96,683 samples reveals alarming statistics Metropolis Healthcare – a multinational chain of diagnostic centres conducted an…
Dr Shailesh Pande, Genetic Counselor Metropolis Healthcare speaks on the trends in genetic diagnostics and the way forward in this…
The promoter Shah family has bough the 27 per cent stake from Warburg Pincus
India’s leading pathology chain Metropolis Healthcare on Thursday said private equity (PE) investor Warburg Pincus has sold its 27% stake…
Metropolis now authorised to conduct swine flu tests in three metro cities
Becomes the first to offer comprehensive reflex testing for conclusive diagnosis in cancer in India
Becomes the first to offer comprehensive reflex testing for conclusive diagnosis in cancer in India